Accelerating Psychedelic Research
- 3 days ago
- 3 min read
Recently, the US took a historic leap in fast-tracking psychedelic research. Focused on accelerating research and increasing colaboration between governmental agencies This move represents a broad victory for entheogens as a whole. People have been using these tools for thousands of years for healing and accessing higher states of consciousness. It’s a reminder that sometimes the most helpful things are the least synthesized.
Bringing us back to our favorite entheogen, mushrooms. Not only do they provide the same benefits as other psychedelics at "heroic doses," but they do so with fewer risks of adverse effects. Unless you find yourself laughing so hard that you manage to pee yourself before getting to the bathroom. I say this from experience 😂.
I’m a big proponent of mushrooms because they offer, in my opinion, the most economical benefit of anything being studied in this realm right now. Not just from a medical standpoint, but industrial too. The applications for mushrooms, mycelium, and their byproducts can literally transform entire industries if given the proper attention. In fact, they already are.
The Executive Order and What It Means for Psychedelic Research
The executive order to accelerate psychedelic research signals a shift in how the US government views these substances. For decades, psychedelics were locked behind strict regulations, limiting scientific exploration. Now, the door is opening wider.
This order aims to:
Speed up clinical trials for psychedelics like ibogaine, psilocybin and MDMA.
Increase funding for research into therapeutic uses.
Encourage collaboration between government agencies, universities, and private companies.
Remove some regulatory barriers that slowed progress.
The implications are profound. Psychedelic compounds have shown promise in treating depression, PTSD, addiction, and anxiety. Fast-tracking research means faster access to new therapies for millions.
It also means more data, better understanding, and safer protocols. This is crucial for integrating psychedelics into mainstream medicine responsibly.
Why Mushrooms Stand Out in Psychedelic Research
Among psychedelics, psilocybin mushrooms hold a special place. They are natural, widely studied, and have a long history of use. Their benefits extend beyond mental health.
Medical Benefits
Psilocybin has been shown to:
Reduce symptoms of treatment-resistant depression.
Alleviate anxiety in terminal illness.
Help break addiction cycles.
Enhance emotional processing and cognitive flexibility.
These effects come with fewer side effects compared to synthetic psychedelics. The risk profile is favorable, especially when used in controlled settings.
Industrial and Environmental Potential
Mushrooms and mycelium are not just medicine. They are powerful tools for sustainability and innovation.
Mycelium can be used to create biodegradable packaging, replacing plastics.
It can help remediate polluted soils by breaking down toxins.
Mushroom-based materials are being developed for construction, textiles, and even leather alternatives.
This dual role as medicine and material makes mushrooms a unique asset in the bio-economy.

Mycelium network expanding underground, illustrating nature’s hidden power and potential.
Integrating Modern Tools with Ancient Wisdom
The executive order is a modern step, but it builds on ancient knowledge. Indigenous cultures have used entheogens for millennia to heal and connect with higher states. This continuity is vital.
We are tuning into that ancient frequency with modern tools. Lab-grade grow systems, precise dosing, and clinical protocols enhance safety and efficacy. This blend of old and new creates a powerful platform for discovery.
Final Thoughts
The executive order to accelerate psychedelic research is a landmark moment. It opens pathways for healing, innovation, and transformation. Mushrooms stand at the center of this movement, offering both ancient wisdom and modern utility.
As we cultivate this new era, remember the prophetic words that have guided many in the mycology community: "Semper In Excretia Sumus Solim Profundum Variat" — "We are all in the shit, only the depth varies."
Disclaimer: This post is for informational purposes only and does not constitute medical advice. Always consult a healthcare professional before using psychedelics or related products.
350x350_edited.png)
